Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A differentiation roadmap of murine placentation at single-cell resolution. | Cell Discov | 2023 | 36928215 | PubTator, text mining | PubMed |
| Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital. | Front Oncol | 2023 | 36923436 | PubTator, text mining | PubMed |
| Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene. | Front Oncol | 2023 | 36910630 | PubTator, text mining | PubMed |
| Esophageal Atresia With or Without Tracheoesophageal Fistula: Comorbidities, Genetic Evaluations, and Neonatal Outcomes. | Cureus | 2023 | 36909054 | PubTator, text mining | PubMed |
| Single-cell analyses reveal distinct expression patterns and roles of long non-coding RNAs during hESC differentiation into pancreatic progenitors. | Stem Cell Res Ther | 2023 | 36907881 | PubTator, text mining | PubMed |
| Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges. | Int J Mol Sci | 2023 | 36902015 | PubTator, text mining | PubMed |
| Genetic Characteristics of Primary Cutaneous Malignant Melanoma in Koreans Compared With Western Populations. | In Vivo | 2023 | 36881068 | PubTator, text mining | PubMed |
| The progress in our understanding of CIN in breast cancer research. | Front Oncol | 2023 | 36874134 | PubTator, text mining | PubMed |
| Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma. | Ther Adv Med Oncol | 2023 | 36872946 | PubTator, text mining | PubMed |
| Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer. | Sci Data | 2023 | 36869083 | PubTator, text mining | PubMed |
| Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer. | Dis Markers | 2023 | 36865499 | PubTator, text mining | PubMed |
| Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids. | Cell Regen | 2023 | 36864321 | PubTator, text mining | PubMed |
| Protocol to generate induced trophoblast stem cells from embryonic stem cells in mice. | STAR Protoc | 2023 | 36853659 | PubTator, text mining | PubMed |
| Metabonomic analysis of human and 12 kinds of livestock mature milk. | Food Chem X | 2023 | 36845482 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis. | Int J Mol Sci | 2023 | 36835562 | PubTator, text mining | PubMed |
| Secretome of Adipose-Derived Stem Cells Cultured in Platelet Lysate Improves Migration and Viability of Keratinocytes. | Int J Mol Sci | 2023 | 36834932 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling. | Int J Mol Sci | 2023 | 36834870 | PubTator, text mining | PubMed |
| CTTN Overexpression Confers Cancer Stem Cell-like Properties and Trastuzumab Resistance via DKK-1/WNT Signaling in HER2 Positive Breast Cancer. | Cancers (Basel) | 2023 | 36831511 | PubTator, text mining | PubMed |
| hPSC-derived lung organoids: Potential opportunities and challenges. | Heliyon | 2023 | 36814627 | PubTator, text mining | PubMed |
| In silico discovery of small molecules for efficient stem cell differentiation into definitive endoderm. | Stem Cell Reports | 2023 | 36801003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=18